Procedures for design validation must address risk analysis where appropriate.
How you respond to Form 483 observations matters.
An FDA inspection should never be confused with a notified body audit.
You can’t just validate processes—you have to monitor them, too.
FDA takes control of non-conforming product seriously.
A monumental screw up, complete with bad quality, regulatory and statutory practices.